跳至主要内容
临床试验/NCT03148574
NCT03148574已完成3 期

Intrauterine Misoprostol Versus Intravenous Oxytocin Infusion During Cesarean Delivery to Reduce Intraoperative and Postoperative Blood Loss: A Randomized Clinical Trial.

Assiut University1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2017年7月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
240
试验地点
1
主要终点
amount of intraoperative blood loss

研究概览

简要总结

Bleeding is still the major cause of mortality and morbidity in postpartum period. World health organization has reported 585000 deaths for pregnancy each year. Twenty five percent of cases die from post-partum bleeding. Mean amount of blood lost is 500 ml during normal vaginal delivery, 1000 ml in cesarean section, and 3500 ml during cesarean section with emergency hysterectomy

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • 1-Uncomplicated pregnancy, 2-Had no hypersensitivity or contraindications to prostaglandins.
  • 3-Had no history of coagulopathy. 4-Accepting to participate in the study.

排除标准

  • \1-women with anemia (Haemoglobin <8 gram ). 2 placental abnormality (e.g placenta previa,placenta abruption )
  • History of complications at previous pregnancy especially postpartum hemorrhage. 4- Maternal hypertension , current or previous history of heart disease ,liver ,Renal disorders or known coagulopathy

研究组 & 干预措施

misoprostol

Experimental

intrauterine 400 microgram

干预措施: Misoprostol (Drug)

oxytocin

Active Comparator

intravenous infusion 10 units

干预措施: Oxytocin (Drug)

结局指标

主要结局

amount of intraoperative blood loss

时间窗: 30 minutes

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Abbas

principal investigator

Assiut University

研究点 (1)

Loading locations...

相似试验